Immuta, Inc. is a data security company that specializes in providing organizations with a platform for managing data privacy, security, and access control. The Immuta Data Security Platform enables users to discover and classify sensitive data, implement access control policies, and monitor data usage without the need for coding. This automated data governance solution supports self-service access to data while ensuring compliance with various regulations. Immuta is utilized by a diverse range of industries, including finance, healthcare, government, and manufacturing, to facilitate cloud migration and secure collaboration. Founded in 2014 and headquartered in College Park, Maryland, with additional offices in Boston, Massachusetts and Columbus, Ohio, Immuta has established itself as a trusted partner for Fortune 500 companies and government agencies worldwide.
Xometry offers an AI-enabled marketplace for on-demand manufacturing services, connecting buyers with manufacturers for efficient sourcing of parts and assemblies. Services include CNC machining, 3D printing, injection molding, urethane casting, die casting, and more.
Xometry offers an AI-enabled marketplace for on-demand manufacturing services, connecting buyers with manufacturers for efficient sourcing of parts and assemblies. Services include CNC machining, 3D printing, injection molding, urethane casting, die casting, and more.
Xometry offers an AI-enabled marketplace for on-demand manufacturing services, connecting buyers with manufacturers for efficient sourcing of parts and assemblies. Services include CNC machining, 3D printing, injection molding, urethane casting, die casting, and more.
Senseonics
Venture Round in 2014
Senseonics Holdings, Inc. is a medical technology company based in Germantown, Maryland, specializing in the development and commercialization of continuous glucose monitoring (CGM) systems for individuals with diabetes. Founded in 1996, the company focuses on innovative and long-term implantable glucose monitoring solutions that utilize advanced fluorescence sensing technology. Its flagship products, Eversense and Eversense XL, are implantable CGM systems designed to monitor glucose levels for up to 90 and 180 days, respectively. These products aim to provide users with a reliable and stable means of glucose management, enhancing their ability to live confidently and manage their diabetes effectively. The majority of Senseonics' revenue comes from international markets, reflecting its strong presence in Europe.
Bravo Health
Series A in 2012
Bravo Health, Inc. is a managed care organization that specializes in providing Medicare Advantage options, catering specifically to Medicare beneficiaries, including those who are dually eligible for Medicare and Medicaid. The company offers a range of plans, including special needs plans for individuals receiving institutional care or those with chronic health conditions, as well as private fee-for-service plans that allow members to choose their healthcare providers. Additionally, Bravo Health provides Part D prescription drug plans to cover medication needs. The company operates in multiple states, including Delaware, Maryland, Pennsylvania, Texas, and Washington, and has expanded its services to offer prescription drug coverage in 43 states. Founded in 1996 and headquartered in Baltimore, Maryland, Bravo Health was previously known as Elder Health, Inc.